Market Currents
Arena Pharmaceuticals (ARNA +38%) resumes trading at $13.50 following the FDA's approval of its...
-
Wednesday, June 27, 2012, 1:47 PM ETArena Pharmaceuticals (ARNA +38%) resumes trading at $13.50 following the FDA's approval of its weight-loss drug Belviq - formerly known as lorcaserin.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 9 comments:
Solomon asked for one thing....WISDOM